Alphabet subsidiary GV has bolstered its biotech focus by bringing in Rosana Kapeller as an entrepreneur-in-residence and David Reshef as venture partner.
GV, a corporate venturing subsidiary of internet and technology conglomerate Alphabet, has hired Rosana Kapeller, former chief scientific officer at biotechnology company Nimbus Therapeutics, as its first entrepreneur-in-residence for life sciences.
In her new role, Kapeller will concentrate on technologies that apply machine learning technology to the healthcare and life sciences sectors, with the intention of running a startup developing one of those technologies.
Kapeller spent eight years as the founding chief scientific officer of Nimbus up to March 2018,…
